This is related to the fact that although ARPKD is a recessive disease, in which heterozygous carriers should not show any clinical manifestation of the disease, the data suggest heterozygous for PKHD1 mutations have an increased risk of PLD and mild PKD [30,31]. This evidence concerns the gene PKHD1 and autosomal recessive polycystic kidney disease.